Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Mader, JK; Lilly, LC; Aberer, F; Pachatz, J; Korsatko, S; Damsbo, P; Pieber, TR.
PaQ®, a simple 3-day basal/bolus insulin delivery device, in people with type 2 diabetes.
Biomed Tech (Berl). 2013; 58 Suppl 1(1): Doi: 10.1515/bmt-2013-4038
Web of Science PubMed FullText FullText_MUG

Leading authors Med Uni Graz: Mader Julia
Co-authors Med Uni Graz: Aberer Felix; Korsatko Stefan; Pieber Thomas
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: PaQ, a simple 3-day insulin delivery device, is a patch on device that provides set basal rates and bolus insulin on demand. PaQ was designed for people with type 2 diabetes mellitus to reduce the barriers of multiple daily insulin injections. A study assessed feasibility of use, method of transition, glycemic control, patient reported outcomes and safety in people with type 2 diabetes using PaQ. PaQ performed as expected. Data suggest ease of use, reduction of barriers to insulin therapy and a trend toward a slight improvement in glycemic control. These findings are important because improved medication experience may result in better compliance and subsequent clinical outcomes.